Company profile
ABBOTT MEDICAL
ABBOTT MEDICAL has 3 AI-enabled medical devices on the FDA list. The first decision was on June 8, 2021 and the most recent on April 24, 2026 (OPTIS Mobile Next Imaging System (1014932); OPTIS Integrated Next Imaging System (1014933); Ultreon 3.0 Software Upgrade Kit (ULTR300001)). Its most common review panel is Radiology (2 devices).
3AI devices
2021First decision
2026Latest decision
2Specialties
Per year
202120252026
By specialty
Related guides
Timeline
- OPTIS Mobile Next Imaging System (1014932); OPTIS Integrated Next Imaging System (1014933); Ultreon 3.0 Software Upgrade Kit (ULTR300001) · Radiology · NQQ
- Assert-IQ (DM5100) · Cardiovascular · MXD
- OPTIS Mobile Next Imaging System, OPTIS Integrated Next Imaging System · Radiology · NQQ